Aug 17, 2023
Press communication Lund, Sweden, August 17, 2023 This is a translation of the Swedish press release published 2023-08-17 Neola Medical AB (the “Company”) has appointed ABG Sundal Collier (“ABGSC”) as liquidity provider for the Company’s shares listed on Nasdaq...
Aug 16, 2023
Yesterday, Neola Medical released the Q2 report for 2023. In connection, CEO Hanna Sjöström and CFO Christian Gyllenberg presented the report in a videoconference. Apart from presenting the company’s financials and the significant events from this quarter, they...
Aug 15, 2023
Idag släppte Neola Medical sin Q2-rapport för 2023. Hör CEO Hanna Sjöström kommentera rapporten och däribland även det fortsatta arbetet med marknadsförberedelser inför lansering med ett nytt kontor i Palo Alto, Silicon Valley, besöket på PAS-konferensen i Washington,...
Aug 15, 2023
This is a translation of the Swedish press release published 2023-08-15, 08.00 CEST Neola Medical AB (publ) today publishes the Q2 report of 2023 (in Swedish). The report is available at the company’s website and is attached to the press release. During the...
Aug 8, 2023
Press communication Lund, Sweden, August 8, 2023 This is a translation of the Swedish press release published 2023-08-08 Neola Medical AB (publ) announces today that the company’s trademark, Neola®, has been registered in the U.S, the company’s most important market....
Aug 7, 2023
This is a translation of the Swedish press release published 2023-08-07 Neola Medical AB (publ) invites to presentation of the Q2-report of 2023, Tuesday August 15, 2023, at 11am (CET, 11.00). The presentation will be held online as a video conference. The Q2-report...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
